Global Kidney/Renal Function Test Market Report (2025–2036)
Market Overview
The global kidney/renal function test market was valued at USD xxxx million in 2025 and is projected to reach USD xxxx million by 2036, growing at a CAGR of xx%. Renal function tests are critical diagnostic tools used to evaluate kidney health, detect chronic kidney disease (CKD), and monitor treatment outcomes. Rising prevalence of diabetes, hypertension, and CKD, coupled with increasing awareness of preventive healthcare, is driving market growth. Technological advancements in diagnostic assays and point-of-care testing are further accelerating adoption.
Impact of COVID-19
The pandemic disrupted routine diagnostic services in 2020, reducing patient visits for non-emergency tests. However, COVID-19 highlighted the importance of renal monitoring, particularly in patients with severe infections and comorbidities. Post-pandemic recovery has been marked by increased investments in diagnostic infrastructure, telemedicine integration, and home-based testing solutions.
Market Segmentation
By Type
- Urine Test – includes urinalysis, microalbumin tests, and creatinine clearance.
- Blood Test – includes serum creatinine, blood urea nitrogen (BUN), and estimated glomerular filtration rate (eGFR).
- Point-of-Care Tests – rapid diagnostic kits for immediate kidney function assessment.
- Others – advanced biomarker assays and imaging-assisted diagnostics.
By Application
- Hospitals – primary centers for renal diagnostics and patient monitoring.
- Diagnostic Laboratories – independent labs offering comprehensive renal panels.
- Research Laboratories and Institutes – academic and clinical research on kidney biomarkers.
- Others – homecare settings and mobile diagnostic services.
Regional Analysis
- North America: Largest market; driven by high prevalence of CKD, advanced healthcare infrastructure, and strong presence of diagnostic companies.
- Europe: Significant growth; Germany, U.K., and France lead adoption with strong reimbursement frameworks and preventive healthcare initiatives.
- Asia-Pacific: Fastest-growing region; China, India, and Japan expanding diagnostic capabilities due to rising diabetes and hypertension cases.
- South America: Brazil and Argentina showing growth in diagnostic laboratories and public health initiatives.
- Middle East & Africa: Emerging demand; increasing investments in healthcare infrastructure and awareness campaigns for CKD prevention.
Key Players
- Siemens Healthineers
- Beckman Coulter
- Roche Diagnostics
- Abbott Laboratories
- Sysmex Corporation
- Nova Biomedical
- Urit Medical
- Arkray Inc.
- Opti Medical Systems
- Acon Laboratories
- 77 Elektronika
- Randox Laboratories
Additional Players:
- Thermo Fisher Scientific (U.S.)
- Becton, Dickinson and Company (U.S.)
- Bio-Rad Laboratories (U.S.)
- HORIBA Medical (Japan)
- Mindray Medical (China)
- Quest Diagnostics (U.S.)
- Laboratory Corporation of America (LabCorp, U.S.)
- DiaSys Diagnostic Systems (Germany)
Porter’s Five Forces
- Threat of New Entrants – Moderate; requires regulatory approvals and advanced diagnostic technologies.
- Bargaining Power of Suppliers – Moderate; reagents and consumables influence costs.
- Bargaining Power of Buyers – High; hospitals and labs demand cost-effective, accurate tests.
- Threat of Substitutes – Low; renal function tests remain essential for CKD diagnosis.
- Industry Rivalry – High; global players compete on innovation, pricing, and distribution.
SWOT Analysis
Strengths:
- Essential role in CKD diagnosis and monitoring
- Established global diagnostic companies
- Growing demand for preventive healthcare
Weaknesses:
- High costs of advanced biomarker assays
- Limited access in low-income regions
- Dependence on reimbursement policies
Opportunities:
- Growth in point-of-care and home-based testing
- Expansion in Asia-Pacific and Middle East markets
- Rising demand for personalized medicine and biomarker discovery
Threats:
- Regulatory hurdles for new diagnostic technologies
- Competition from alternative diagnostic methods
- Supply chain vulnerabilities
Trend Analysis
- Point-of-Care Diagnostics: Increasing adoption of portable renal test kits.
- Digital Health Integration: Telemedicine and remote monitoring improving patient outcomes.
- Biomarker Discovery: Advanced assays for early CKD detection.
- Automation in Labs: High-throughput analyzers enhancing efficiency.
- Global Collaborations: Partnerships between diagnostic firms and healthcare providers.
Drivers & Challenges
Drivers:
- Rising prevalence of CKD, diabetes, and hypertension
- Increasing demand for preventive diagnostics
- Technological advancements in renal assays
- Expansion of healthcare infrastructure in emerging markets
Challenges:
- High costs of advanced diagnostic technologies
- Regulatory complexity across regions
- Limited awareness in developing countries
- Shortage of skilled laboratory professionals
Value Chain Analysis
- Raw Materials: Reagents, consumables, and diagnostic kits.
- Manufacturing: Production of analyzers, test kits, and biomarker assays.
- Distribution: Hospitals, diagnostic labs, clinics, and homecare providers.
- End Users: Patients, healthcare providers, and research institutions.
- After-Sales Services: Technical support, calibration, and training.
Quick Recommendations for Stakeholders
- Manufacturers: Invest in point-of-care and home-based renal testing solutions.
- Healthcare Providers: Expand adoption of digital health platforms for CKD monitoring.
- Policy Makers: Strengthen reimbursement frameworks and awareness campaigns.
- Investors: Focus on Asia-Pacific and Europe for high-growth opportunities.
- Research Institutions: Collaborate with diagnostic firms to accelerate biomarker innovation.
Explore more reports here-
https://westernmarketresearch.com/reports
1. Market Overview of Kidney/Renal Function Test
1.1 Kidney/Renal Function Test Market Overview
1.1.1 Kidney/Renal Function Test Product Scope
1.1.2 Market Status and Outlook
1.2 Kidney/Renal Function Test Market Size by Regions: 2015 VS 2021 VS 2026
1.3 Kidney/Renal Function Test Historic Market Size by Regions
1.4 Kidney/Renal Function Test Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Kidney/Renal Function Test Sales Market by Type
2.1 Global Kidney/Renal Function Test Historic Market Size by Type
2.2 Global Kidney/Renal Function Test Forecasted Market Size by Type
2.3 Urine Test
2.4 Blood Test
3. Covid-19 Impact Kidney/Renal Function Test Sales Market by Application
3.1 Global Kidney/Renal Function Test Historic Market Size by Application
3.2 Global Kidney/Renal Function Test Forecasted Market Size by Application
3.3 Hospitals
3.4 Diagnostic Laboratories
3.5 Research Laboratories and Institutes
3.6 Others
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Kidney/Renal Function Test Production Capacity Market Share by Manufacturers
4.2 Global Kidney/Renal Function Test Revenue Market Share by Manufacturers
4.3 Global Kidney/Renal Function Test Average Price by Manufacturers
5. Company Profiles and Key Figures in Kidney/Renal Function Test Business
5.1 Siemens
5.1.1 Siemens Company Profile
5.1.2 Siemens Kidney/Renal Function Test Product Specification
5.1.3 Siemens Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.2 Beckman Coulter
5.2.1 Beckman Coulter Company Profile
5.2.2 Beckman Coulter Kidney/Renal Function Test Product Specification
5.2.3 Beckman Coulter Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.3 Roche
5.3.1 Roche Company Profile
5.3.2 Roche Kidney/Renal Function Test Product Specification
5.3.3 Roche Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.4 Abbott
5.4.1 Abbott Company Profile
5.4.2 Abbott Kidney/Renal Function Test Product Specification
5.4.3 Abbott Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.5 Sysmex
5.5.1 Sysmex Company Profile
5.5.2 Sysmex Kidney/Renal Function Test Product Specification
5.5.3 Sysmex Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.6 Nova Biomedical
5.6.1 Nova Biomedical Company Profile
5.6.2 Nova Biomedical Kidney/Renal Function Test Product Specification
5.6.3 Nova Biomedical Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.7 Urit Medical
5.7.1 Urit Medical Company Profile
5.7.2 Urit Medical Kidney/Renal Function Test Product Specification
5.7.3 Urit Medical Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.8 Arkray
5.8.1 Arkray Company Profile
5.8.2 Arkray Kidney/Renal Function Test Product Specification
5.8.3 Arkray Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.9 Opti Medical
5.9.1 Opti Medical Company Profile
5.9.2 Opti Medical Kidney/Renal Function Test Product Specification
5.9.3 Opti Medical Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.10 Acon Laboratories
5.10.1 Acon Laboratories Company Profile
5.10.2 Acon Laboratories Kidney/Renal Function Test Product Specification
5.10.3 Acon Laboratories Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.11 77 Elektronika
5.11.1 77 Elektronika Company Profile
5.11.2 77 Elektronika Kidney/Renal Function Test Product Specification
5.11.3 77 Elektronika Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
5.12 Randox Laboratories
5.12.1 Randox Laboratories Company Profile
5.12.2 Randox Laboratories Kidney/Renal Function Test Product Specification
5.12.3 Randox Laboratories Kidney/Renal Function Test Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Kidney/Renal Function Test Market Size
6.2 North America Kidney/Renal Function Test Key Players in North America
6.3 North America Kidney/Renal Function Test Market Size by Type
6.4 North America Kidney/Renal Function Test Market Size by Application
7. East Asia
7.1 East Asia Kidney/Renal Function Test Market Size
7.2 East Asia Kidney/Renal Function Test Key Players in North America
7.3 East Asia Kidney/Renal Function Test Market Size by Type
7.4 East Asia Kidney/Renal Function Test Market Size by Application
8. Europe
8.1 Europe Kidney/Renal Function Test Market Size
8.2 Europe Kidney/Renal Function Test Key Players in North America
8.3 Europe Kidney/Renal Function Test Market Size by Type
8.4 Europe Kidney/Renal Function Test Market Size by Application
9. South Asia
9.1 South Asia Kidney/Renal Function Test Market Size
9.2 South Asia Kidney/Renal Function Test Key Players in North America
9.3 South Asia Kidney/Renal Function Test Market Size by Type
9.4 South Asia Kidney/Renal Function Test Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Kidney/Renal Function Test Market Size
10.2 Southeast Asia Kidney/Renal Function Test Key Players in North America
10.3 Southeast Asia Kidney/Renal Function Test Market Size by Type
10.4 Southeast Asia Kidney/Renal Function Test Market Size by Application
11. Middle East
11.1 Middle East Kidney/Renal Function Test Market Size
11.2 Middle East Kidney/Renal Function Test Key Players in North America
11.3 Middle East Kidney/Renal Function Test Market Size by Type
11.4 Middle East Kidney/Renal Function Test Market Size by Application
12. Africa
12.1 Africa Kidney/Renal Function Test Market Size
12.2 Africa Kidney/Renal Function Test Key Players in North America
12.3 Africa Kidney/Renal Function Test Market Size by Type
12.4 Africa Kidney/Renal Function Test Market Size by Application
13. Oceania
13.1 Oceania Kidney/Renal Function Test Market Size
13.2 Oceania Kidney/Renal Function Test Key Players in North America
13.3 Oceania Kidney/Renal Function Test Market Size by Type
13.4 Oceania Kidney/Renal Function Test Market Size by Application
14. South America
14.1 South America Kidney/Renal Function Test Market Size
14.2 South America Kidney/Renal Function Test Key Players in North America
14.3 South America Kidney/Renal Function Test Market Size by Type
14.4 South America Kidney/Renal Function Test Market Size by Application
15. Rest of the World
15.1 Rest of the World Kidney/Renal Function Test Market Size
15.2 Rest of the World Kidney/Renal Function Test Key Players in North America
15.3 Rest of the World Kidney/Renal Function Test Market Size by Type
15.4 Rest of the World Kidney/Renal Function Test Market Size by Application
16 Kidney/Renal Function Test Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter
Market Segmentation
By Type
- Urine Test – includes urinalysis, microalbumin tests, and creatinine clearance.
- Blood Test – includes serum creatinine, blood urea nitrogen (BUN), and estimated glomerular filtration rate (eGFR).
- Point-of-Care Tests – rapid diagnostic kits for immediate kidney function assessment.
- Others – advanced biomarker assays and imaging-assisted diagnostics.
By Application
- Hospitals – primary centers for renal diagnostics and patient monitoring.
- Diagnostic Laboratories – independent labs offering comprehensive renal panels.
- Research Laboratories and Institutes – academic and clinical research on kidney biomarkers.
- Others – homecare settings and mobile diagnostic services.
Regional Analysis
- North America: Largest market; driven by high prevalence of CKD, advanced healthcare infrastructure, and strong presence of diagnostic companies.
- Europe: Significant growth; Germany, U.K., and France lead adoption with strong reimbursement frameworks and preventive healthcare initiatives.
- Asia-Pacific: Fastest-growing region; China, India, and Japan expanding diagnostic capabilities due to rising diabetes and hypertension cases.
- South America: Brazil and Argentina showing growth in diagnostic laboratories and public health initiatives.
- Middle East & Africa: Emerging demand; increasing investments in healthcare infrastructure and awareness campaigns for CKD prevention.
Key Players
- Siemens Healthineers
- Beckman Coulter
- Roche Diagnostics
- Abbott Laboratories
- Sysmex Corporation
- Nova Biomedical
- Urit Medical
- Arkray Inc.
- Opti Medical Systems
- Acon Laboratories
- 77 Elektronika
- Randox Laboratories
Additional Players:
- Thermo Fisher Scientific (U.S.)
- Becton, Dickinson and Company (U.S.)
- Bio-Rad Laboratories (U.S.)
- HORIBA Medical (Japan)
- Mindray Medical (China)
- Quest Diagnostics (U.S.)
- Laboratory Corporation of America (LabCorp, U.S.)
- DiaSys Diagnostic Systems (Germany)
